That's not true. Odivo patient assistance project is the first patient assistance project for tumor immunotherapy for lung cancer patients in China. It aims to provide drug assistance for low-income poor patients with non-small cell lung cancer (non-small cell lung cancer), reduce the pressure on patients to pay, help more patients achieve long-term survival and improve their quality of life. More than 200 hospitals in more than 80 cities across the country will participate in aid projects. With the full launch of the project, more patients with non-small cell lung cancer will have the opportunity to receive innovative tumor immunotherapy.